189 related articles for article (PubMed ID: 38778174)
21. Identification of potential drug targets for allergic diseases from a genetic perspective: A mendelian randomization study.
Wang H; Pang J; Zhou Y; Qi Q; Tang Y; Gul S; Sheng M; Dan J; Tang W
Clin Transl Allergy; 2024 Apr; 14(4):e12350. PubMed ID: 38573314
[TBL] [Abstract][Full Text] [Related]
22. Based on systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for diabetes.
Li H; Li W; Li D; Yuan L; Xu Y; Su P; Wu L; Zhang Z
Front Endocrinol (Lausanne); 2024; 15():1366290. PubMed ID: 38915894
[TBL] [Abstract][Full Text] [Related]
23. Causal associations between liver enzymes and diabetic microvascular complications: A univariable and multivariable Mendelian randomization.
Li Y; Zhang Q
PLoS One; 2024; 19(1):e0296894. PubMed ID: 38232082
[TBL] [Abstract][Full Text] [Related]
24. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases.
Zheng J; Haberland V; Baird D; Walker V; Haycock PC; Hurle MR; Gutteridge A; Erola P; Liu Y; Luo S; Robinson J; Richardson TG; Staley JR; Elsworth B; Burgess S; Sun BB; Danesh J; Runz H; Maranville JC; Martin HM; Yarmolinsky J; Laurin C; Holmes MV; Liu JZ; Estrada K; Santos R; McCarthy L; Waterworth D; Nelson MR; Smith GD; Butterworth AS; Hemani G; Scott RA; Gaunt TR
Nat Genet; 2020 Oct; 52(10):1122-1131. PubMed ID: 32895551
[TBL] [Abstract][Full Text] [Related]
25. Plasma proteins and onset of type 2 diabetes and diabetic complications: Proteome-wide Mendelian randomization and colocalization analyses.
Yuan S; Xu F; Li X; Chen J; Zheng J; Mantzoros CS; Larsson SC
Cell Rep Med; 2023 Sep; 4(9):101174. PubMed ID: 37652020
[TBL] [Abstract][Full Text] [Related]
26. Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome.
Chong M; Sjaarda J; Pigeyre M; Mohammadi-Shemirani P; Lali R; Shoamanesh A; Gerstein HC; Paré G
Circulation; 2019 Sep; 140(10):819-830. PubMed ID: 31208196
[TBL] [Abstract][Full Text] [Related]
27. Associations of genetically determined lipid traits and lipid-modifying agents with the risk of diabetic retinopathy: A Mendelian randomization study.
Li N; Zhang X; Zhang M; Wu L; Li C; Pan Y; Wang W; Ji J; Zheng D
Atherosclerosis; 2023 Mar; 369():9-16. PubMed ID: 36827905
[TBL] [Abstract][Full Text] [Related]
28. Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease.
Wang Z; Li S; Cai G; Gao Y; Yang H; Li Y; Liang J; Zhang S; Hu J; Zheng J
Front Cell Infect Microbiol; 2024; 14():1386506. PubMed ID: 38660492
[TBL] [Abstract][Full Text] [Related]
29. Causal Relationship between Adiponectin and Diabetic Retinopathy: A Mendelian Randomization Study in an Asian Population.
Huang YC; Chang YW; Cheng CW; Wu CM; Liao WL; Tsai FJ
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374471
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic Targets for Diabetic Kidney Disease: Proteome-Wide Mendelian Randomization and Colocalization Analyses.
Zhang W; Ma L; Zhou Q; Gu T; Zhang X; Xing H
Diabetes; 2024 Apr; 73(4):618-627. PubMed ID: 38211557
[TBL] [Abstract][Full Text] [Related]
31. Novel Causal Plasma Proteins for Hypothyroidism: A Large-scale Plasma Proteome Mendelian Randomization Analysis.
Yang H; Chen L; Liu Y
J Clin Endocrinol Metab; 2023 Jan; 108(2):433-442. PubMed ID: 36190832
[TBL] [Abstract][Full Text] [Related]
32. The causal effect of hypertension, intraocular pressure, and diabetic retinopathy: a Mendelian randomization study.
Wang XF; Zhang XW; Liu YJ; Zheng XY; Su MR; Sun XH; Jiang F; Liu ZN
Front Endocrinol (Lausanne); 2024; 15():1304512. PubMed ID: 38379860
[TBL] [Abstract][Full Text] [Related]
33. Association between plasma proteome and pulmonary heart disease: A two-stage Mendelian randomization analysis.
Li S; Ding H; Li Q; Zeng X; Zhang Y; Lai C; Xie X; Tang Y; Lan J
Clin Respir J; 2024 Jun; 18(6):e13775. PubMed ID: 38830831
[TBL] [Abstract][Full Text] [Related]
34. Identification of potential drug targets for insomnia by Mendelian randomization analysis based on plasma proteomics.
Yang N; Shi L; Xu P; Ren F; Lv S; Li C; Qi X
Front Neurol; 2024; 15():1380321. PubMed ID: 38725646
[TBL] [Abstract][Full Text] [Related]
35. Identifying novel proteins for migraine by integrating proteomes from blood and CSF with genome-wide association data.
Niu PP; Zhang R; Zhang C; Li S; Li YS
CNS Neurosci Ther; 2024 Jun; 30(6):e14817. PubMed ID: 38898596
[TBL] [Abstract][Full Text] [Related]
36. Insight into telomere regulation: road to discovery and intervention in plasma drug-protein targets.
Ding K; Zhangwang J; Lei M; Xiong C
BMC Genomics; 2024 Mar; 25(1):231. PubMed ID: 38431573
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses.
Chen J; Xu F; Ruan X; Sun J; Zhang Y; Zhang H; Zhao J; Zheng J; Larsson SC; Wang X; Li X; Yuan S
EBioMedicine; 2023 Mar; 89():104494. PubMed ID: 36857861
[TBL] [Abstract][Full Text] [Related]
38. Genetically Determined Chronic Low-Grade Inflammation and Hundreds of Health Outcomes in the UK Biobank and the FinnGen Population: A Phenome-Wide Mendelian Randomization Study.
Si S; Li J; Tewara MA; Xue F
Front Immunol; 2021; 12():720876. PubMed ID: 34386016
[TBL] [Abstract][Full Text] [Related]
39. Proteome-wide mendelian randomization identifies causal plasma proteins in venous thromboembolism development.
Li H; Zhang Z; Qiu Y; Weng H; Yuan S; Zhang Y; Zhang Y; Xi L; Xu F; Ji X; Hao R; Yang P; Chen G; Zuo X; Zhai Z; Wang C
J Hum Genet; 2023 Dec; 68(12):805-812. PubMed ID: 37537391
[TBL] [Abstract][Full Text] [Related]
40. Identification of plasma protein markers of allergic disease risk: a mendelian randomization approach to proteomic analysis.
Cao Z; Li Q; Li Y; Wu J
BMC Genomics; 2024 May; 25(1):503. PubMed ID: 38773393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
